Free Trial
Mitchell S.

Mitchell S. Analyst Performance

Biotech Analyst at HC Wainwright

Mitchell S. is a stock analyst at HC Wainwright focused in the medical sector, covering 29 publicly traded companies. Over the past year, Mitchell S. has issued 118 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
118 Last 0 Years
Buy Recommendations
86.44% 102 Buy Ratings
Companies Covered
29 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy86.4%102 ratings
Hold9.3%11 ratings
Sell4.2%5 ratings

Out of 118 total stock ratings issued by Mitchell S. at HC Wainwright, the majority (86.4%) have been Buy recommendations, followed by 9.3% Hold and 4.2% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.6% of companies on NASDAQ
28 companies
NYSE
3.4% of companies on NYSE
1 company

Mitchell S., an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
27 companies
93.1%
Manufacturing
2 companies
6.9%

Mitchell S. of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
17 companies
58.6%
MED - DRUGS
9 companies
31.0%
Miscellaneous
2 companies
6.9%
PHARMACEUTICAL PREPARATIONS
1 company
3.4%

Mitchell S.'s Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
6/3/2026Reiterated Rating$55.23Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
6/3/2026Reiterated Rating$7.86$25.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
6/3/2026Boost Price Target$36.28$65.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
6/3/2026Reiterated Rating$14.89$45.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/27/2026Reiterated Rating$29.53Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
5/27/2026Reiterated Rating$76.07$125.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
5/26/2026Reiterated Rating$22.74$50.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
5/22/2026Downgrade$17.47Neutral
Incyte Corporation stock logo
INCY
Incyte
5/21/2026Reiterated Rating$97.08$135.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
5/19/2026Lower Price Target$9.97$15.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/18/2026Reiterated Rating$27.55$50.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
5/18/2026Reiterated Rating$61.93$120.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/18/2026Lower Price Target$50.63$50.00Neutral
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Downgrade$24.63$25.00Neutral
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
5/15/2026Boost Price Target$10.74$25.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
5/14/2026Reiterated Rating$36.18$45.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
5/14/2026Lower Price Target$19.85$35.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/13/2026Lower Price Target$13.99$25.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
5/12/2026Lower Price Target$8.53$25.00Buy
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
5/11/2026Lower Price Target$3.98$11.00Buy
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
5/8/2026Boost Price Target$13.59$25.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/5/2026Reiterated Rating$55.46$55.00Neutral
Incyte Corporation stock logo
INCY
Incyte
5/4/2026Reiterated Rating$96.91$135.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
5/4/2026Lower Price Target$16.11$23.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/30/2026Boost Price Target$74.83$125.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/29/2026Boost Price Target$73.99$120.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
4/29/2026Boost Price Target$63.86$95.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
4/23/2026Reiterated Rating$10.23$20.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/21/2026Reiterated Rating$25.07$50.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4/16/2026Reiterated Rating$21.07Sell
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/15/2026Reiterated Rating$18.69$50.00Buy
Incyte Corporation stock logo
INCY
Incyte
4/15/2026Reiterated Rating$97.69$135.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/13/2026Boost Price Target$59.58$70.00Buy
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
4/13/2026Initiated Coverage$11.41$16.00Buy
Alumis Inc. stock logo
ALMS
Alumis
3/30/2026Lower Price Target$24.80$25.00Buy
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
3/26/2026Initiated Coverage$2.00$7.00Buy
Incyte Corporation stock logo
INCY
Incyte
3/25/2026Reiterated Rating$90.62$135.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
3/25/2026Boost Price Target$13.45$40.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
3/25/2026Boost Price Target$73.05$120.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
3/18/2026Lower Price Target$24.99$50.00Buy
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/16/2026Boost Price Target$7.81$17.00Buy
Incyte Corporation stock logo
INCY
Incyte
3/9/2026Reiterated Rating$95.94$135.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3/3/2026Boost Price Target$15.44$30.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/2/2026Reiterated Rating$16.76Sell
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
3/2/2026Lower Price Target$12.09$22.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/25/2026Lower Price Target$62.62$55.00Neutral
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2/24/2026Lower Price Target$16.09$30.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
2/17/2026Boost Price Target$27.99$45.00Buy
Incyte Corporation stock logo
INCY
Incyte
2/11/2026Reiterated Rating$100.05$135.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
2/10/2026Boost Price Target$25.02$65.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2/2/2026Reiterated Rating$14.48$40.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
1/29/2026Reiterated Rating$71.70Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
1/28/2026Boost Price Target$14.83$25.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/27/2026Reiterated Rating$22.80Sell
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
1/22/2026Lower Price Target$20.76$50.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
1/15/2026Reiterated Rating$16.19$25.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
1/14/2026Reiterated Rating$16.81Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/14/2026Reiterated Rating$21.46Sell
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
1/13/2026Lower Price Target$8.12$10.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
1/13/2026Reiterated Rating$17.28$70.00Buy
Alumis Inc. stock logo
ALMS
Alumis
1/9/2026Reiterated Rating$18.18$40.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
1/7/2026Reiterated Rating$7.03Neutral
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
12/22/2025Boost Price Target$61.15$60.00Neutral
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
12/19/2025Reiterated Rating$65.11$90.00Buy
Alumis Inc. stock logo
ALMS
Alumis
12/18/2025Boost Price Target$11.03$20.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
12/9/2025Upgrade$28.36$45.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
11/28/2025Reiterated Rating$72.66$90.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
11/26/2025Reiterated Rating$28.19Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
11/19/2025Lower Price Target$7.62$30.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
11/13/2025Boost Price Target$31.08$70.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
11/13/2025Reiterated Rating$31.42Neutral
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
11/11/2025Boost Price Target$4.19$10.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/10/2025Lower Price Target$9.52$15.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
11/10/2025Boost Price Target$73.55$110.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
11/3/2025Reiterated Rating$9.01Buy
Neurogene Inc. stock logo
NGNE
Neurogene
10/31/2025Boost Price Target$33.14$65.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/30/2025Boost Price Target$73.46$100.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/27/2025Lower Price Target$14.48$25.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/27/2025Lower Price Target$27.25$40.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
10/27/2025Boost Price Target$7.44$20.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
10/27/2025Lower Price Target$52.67$55.00Neutral
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
10/21/2025Reiterated Rating$66.47Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
10/21/2025Lower Price Target$20.03$40.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
10/21/2025Lower Price Target$9.22$13.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
10/17/2025Lower Price Target$32.36$60.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
10/15/2025Reiterated Rating$66.65$90.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
10/9/2025Reiterated Rating$28.20$45.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/8/2025Reiterated Rating$68.94$95.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
10/7/2025Boost Price Target$8.42$15.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
10/2/2025Boost Price Target$74.94$90.00Buy
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
9/23/2025Reiterated Rating$62.10$80.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/23/2025Reiterated Rating$61.36$95.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
9/22/2025Boost Price Target$77.81$85.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
9/19/2025Boost Price Target$16.11$30.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/16/2025Reiterated Rating$18.94$50.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
9/11/2025Reiterated Rating$24.16$125.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/8/2025Reiterated Rating$25.98$50.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
9/8/2025Initiated Coverage$57.77$60.00Neutral
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
9/5/2025Reiterated Rating$2.52$5.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/2/2025Reiterated Rating$23.70$50.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/2/2025Boost Price Target$42.63$95.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/27/2025Boost Price Target$26.98$50.00Buy
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/27/2025Reiterated Rating$14.47$25.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
8/27/2025Reiterated Rating$28.41$125.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
8/25/2025Reiterated Rating$20.22Sell
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
8/22/2025Boost Price Target$43.24$70.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
8/22/2025Reiterated Rating$11.70$30.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
8/19/2025Reiterated Rating$1.92$7.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
8/19/2025Lower Price Target$1.74$2.00Neutral
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
8/18/2025Reiterated Rating$15.37$45.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
8/15/2025Lower Price Target$4.79$9.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
8/15/2025Reiterated Rating$28.25$125.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/15/2025Reiterated Rating$26.45$44.00Buy
Alumis Inc. stock logo
ALMS
Alumis
8/14/2025Reiterated Rating$4.42$14.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
8/13/2025Lower Price Target$15.99$90.00Buy
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/11/2025Initiated Coverage$12.85$25.00Buy
Boundless Bio, Inc. stock logo
BOLD
Boundless Bio
8/11/2025Lower Price Target$1.10$4.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
8/8/2025Lower Price Target$11.46$25.00Buy